Avenue Therapeutics, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 0.65%40.350.9%$2406.88m
JNJJohnson & Johnson 0.83%150.240.7%$1152.56m
ABBVAbbVie, Inc. 2.42%107.271.9%$937.70m
MRKMerck & Co., Inc. 0.57%81.910.7%$681.87m
BMYBristol-Myers Squibb Co. 0.85%62.311.0%$627.96m
LLYEli Lilly & Co. 3.05%148.501.1%$611.14m
AZNAstraZeneca Plc 1.82%53.741.2%$375.21m
TTNPTitan Pharmaceuticals, Inc. -3.85%3.5017.1%$266.44m
GSKGlaxoSmithKline Plc 0.62%37.500.2%$214.98m
NVSNovartis AG 1.52%91.610.2%$191.99m
ARCTArcturus Therapeutics Holdings, Inc. 12.79%112.010.0%$146.59m
RGENRepligen Corp. 0.60%188.337.1%$92.93m
SBTXSilverback Therapeutics, Inc. 19.05%25.000.0%$88.29m
KNTEKinnate Biopharma, Inc. 11.35%43.460.0%$86.26m
NVONovo Nordisk A/S 0.89%67.810.1%$83.43m

Company Profile

Avenue Therapeutics, Inc. engages in acquiring, licensing, developing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, which is intended for the treatment of moderate to moderately severe post-operative pain. The company was founded on February 9, 2015 and is headquartered in New York, NY.